SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-019729
Filing Date
2018-01-25
Accepted
2018-01-25 16:14:55
Documents
3
Period of Report
2018-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d514046d8k.htm 8-K 22413
2 EX-1.1 d514046dex11.htm EX-1.1 206320
3 EX-5.1 d514046dex51.htm EX-5.1 4552
  Complete submission text file 0001193125-18-019729.txt   234695
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 18548426
SIC: 2834 Pharmaceutical Preparations